Overview

Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease

Status:
Recruiting
Trial end date:
2024-08-30
Target enrollment:
Participant gender:
Summary
This study will be evaluating the safety and efficacy of insulin and glutathione in subjects with Parkinson's Disease compared to placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Gateway Institute for Brain Research
Treatments:
Insulin